Vimian expands in the US

August 4, 2022

Movora, the MedTech segment of the Vimian Group, has acquired New Generation Devices (NGD) a veterinary orthopedic implants company in New Jersey, US.

Founded in 2001, NGD offers a select range of veterinary orthopedic implants to veterinary clinics across the United States with focus on implants for ruptured cruciate ligaments (TPLO) and fracture plates. As part of the transaction, Movora has also acquired an exclusive license in the veterinary field that gives access to Citrate-BP, a synthetic biomaterial to guide tissue regeneration.

The acquired business has annual revenues of around USD 4.5 million.

Read more here.

Recent news

Vimian resolves on a rights issue of up to approx…

The Board of Directors of Vimian Group AB has based on the authorisation from the Annual General Meeting on 2 June 2023, resolved on a rights issue of up to approximately SEK 1,633 million. The purpose of the Rights Issue

Read more

David von Laskowski, Greenfood’s CEO, is awarde…

On the 22 of February, the winners of the “CEO of the Year” award were announced at Kistamässan in Stockholm. The winner in the Large-Cap category was David von Laskowski, Picadeli & Greenfood Group. “CEO of the Year” has been

Read more

Odevo strengthens its UK footprint as Vegner Grou…

Vegner Group Limited is a leading residential property management group in the UK with 475 employees, over 100,000 homes under management and a nationwide reach across 20 office locations. Vegner specializes in serving Residents Management Company (RMC) clients,  bringing further

Read more